Thericon

Thericon is a medical technology company specializing in the development of advanced intraoperative imaging solutions to improve surgical outcomes in oncology. The company's core technology is a patented multispectral imaging (MSI) platform that enables real-time, high-contrast visualization of cancerous tissue, which is often indistinguishable from healthy tissue under standard white light. Their lead application focuses on the resection of bladder cancer, aiming to reduce recurrence rates by ensuring more precise and complete tumor removal. By integrating MSI into existing endoscopic and surgical workflows, Thericon provides surgeons with enhanced diagnostic certainty during procedures.